U.S. markets close in 1 hour 49 minutes
  • S&P 500

    -15.61 (-0.38%)
  • Dow 30

    +81.47 (+0.24%)
  • Nasdaq

    -137.00 (-0.98%)
  • Russell 2000

    +35.04 (+1.57%)
  • Crude Oil

    +3.08 (+5.12%)
  • Gold

    -12.60 (-0.72%)
  • Silver

    +0.00 (+0.02%)

    +0.0024 (+0.20%)
  • 10-Yr Bond

    +0.0200 (+1.23%)

    +0.0029 (+0.21%)

    -0.0970 (-0.09%)

    -1,168.53 (-1.85%)
  • CMC Crypto 200

    -27.01 (-1.96%)
  • FTSE 100

    +49.09 (+0.71%)
  • Nikkei 225

    +82.29 (+0.28%)

AirWare Labs Strengthens Leadership Team With New Director of Product Development

SCOTTSDALE, AZ--(Marketwired - Apr 29, 2014) - AirWare Labs Corp. (OTCQB: AIRW) today announced the addition of Mr. Dan Pool to its executive management team and the appointment of Dr. Lorrie Henderson, Ph.D., MBA to President and Chief Operating Officer.

As Director of Product Development, Pool will oversee product design and development for the AIR® line of nasal dilators. Pool's impressive career spans over 30 years in the field of product design and development. He built his first company, PC MFG, up to $20,000,000 in annual sales and 200 employees over 10 years and sold it along with patents in 1992 in the high seven figure range to 3M Company.

Pool has since sold nearly a dozen inventions to a variety of companies and gained vast experience securing the intellectual property rights for a myriad of products. In 2005, he developed a series of patents for CNS for nasal dilation products, which protected their Breathe Right Nasal Strips. Pool has licensed and developed products for Stanley Works, USG, DAP, 3M Company, Saint-Gobaine, and ShurTech Brands, among others. His unique and methodical approach to developing products is fostered by his belief that everything in everyday life has room for improvement and refinement.

"Dan Pool's accomplishments in product design and innovation, combined with his expertise in patents and intellectual property rights, are tremendous assets to AirWare and our AIR® line," said Jeffrey Rassás, CEO of AirWare Labs. "We are excited to have Dan join us in our mission to improve lives through better breathing."

Dr. Henderson will continue in his new role as President and COO to further the business strategy and increase brand awareness, profitability and shareholder value globally. Dr. Henderson brings over 25 years of leadership experience in the field of Healthcare/Behavioral Health. He earned his bachelor's degree from Florida Atlantic University, his master's degree from Florida International University, a Ph.D. from Barry University in Florida and an MBA, summa cum laude, from Jones International University.

AirWare Labs recently announced production on a branded video featuring TV and movie personalities Vincent Kartheiser (of AMC's drama Mad Men) and Adam Herschman. The company also announced plans for a sales and manufacturing expansion into China and a licensing agreement with Breathe Active, LLC earlier this year. AIR™ ALLERGY was selected as a 2014 Visionary Award Finalist for the VISION® Consumer Products Conference in Dallas, and in 2013 AirWare Labs announced a national rollout into 7,500 Walgreen's stores.

About AirWare Labs Corporation:

AirWare Labs Corp. [publicly traded as (OTCQB: AIRW)] provides patented and innovative technology solutions for consumer products that promote better health through breathing and enhanced wellbeing. AirWare Labs' products are marketed under the brand name of AIR®. AIR® products utilize an FDA approved medical grade silicone, molded as an intranasal Air Breathe dilator, to act as the delivery system. This AIR® microstructure enhances normal nasal airflow with every breath -- clinically proven to deliver up to 40% more oxygen.

Some AIR® products are infused with essential oils with unique healing properties including antibacterial and therapeutic defense against airborne allergens, viruses and bacteria. AIR® Allergy and Travel products provide additional defense in the form of an integrated filter media from 3M to remove microscopic particles that carry viruses, allergens and bacteria. Other AIR® specialty products help provide and performance enhancements and relief from congestion, insomnia, headaches, nausea, and snoring. For more product information, please visit: http://www.airwarelabs.com or company information visit: http://airwarelabscorp.com.

Forward-Looking Statement: The statements in this press release regarding any implied or perceived benefits from the release by AirWare Labs Corp. of its AIR ALLERGY™ product are forward-looking statements. Such statements involve risks and uncertainties, including, but not limited to, risks and effects of legal and administrative proceedings and governmental regulation, especially in a foreign country, future financial and operational results, competition, general economic conditions, and the ability to manage and continue growth.

Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include the introduction of new technology, market conditions and those set forth in reports or documents we file from time to time with the SEC. We undertake no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.